Header Logo

Search Result Details

Back to Search Results
This page shows the details of why an item matched the keywords from your search.
Search Results
KIRKWOOD, JOHN
One or more keywords matched the following items that are connected to KIRKWOOD, JOHN
Item TypeName
Concept CTLA-4 Antigen
Academic Article Next generation of immunotherapy for melanoma.
Academic Article Tremelimumab (CP-675,206): a fully human anticytotoxic T lymphocyte-associated antigen 4 monoclonal antibody for treatment of patients with advanced cancers.
Academic Article Tremelimumab, a fully human monoclonal IgG2 antibody against CTLA4 for the potential treatment of cancer.
Academic Article CTLA-4-blocking immunotherapy with ipilimumab for advanced melanoma.
Academic Article Meeting report from the Third Global Workshop on Melanoma.
Academic Article Evaluation of six CTLA-4 polymorphisms in high-risk melanoma patients receiving adjuvant interferon therapy in the He13A/98 multicenter trial.
Academic Article Adjuvant therapy for melanoma.
Academic Article A multi-factorial genetic model for prognostic assessment of high risk melanoma patients receiving adjuvant interferon.
Academic Article Differing patterns of circulating regulatory T cells and myeloid-derived suppressor cells in metastatic melanoma patients receiving anti-CTLA4 antibody and interferon-a or TLR-9 agonist and GM-CSF with peptide vaccination.
Academic Article Combination central tolerance and peripheral checkpoint blockade unleashes antimelanoma immunity.
Academic Article PD-1 Immune Checkpoint Inhibitors and Immune-Related Adverse Events: Understanding the Upside of the Downside of Checkpoint Blockade.
Academic Article Reactivation of tuberculosis in cancer patients following administration of immune checkpoint inhibitors: current evidence and clinical practice recommendations.
Academic Article Impact of checkpoint blockade on cancer vaccine-activated CD8+ T cell responses.
Academic Article CTLA-4 blockade and interferon-a induce proinflammatory transcriptional changes in the tumor immune landscape that correlate with pathologic response in melanoma.
Academic Article Enhanced immune activation within the tumor microenvironment and circulation of female high-risk melanoma patients and improved survival with adjuvant CTLA4 blockade compared to males.
Search Criteria
  • CTLA 4 Antigen